Gland Pharma Ltd
NSE:GLAND

Watchlist Manager
Gland Pharma Ltd Logo
Gland Pharma Ltd
NSE:GLAND
Watchlist
Price: 1 680.6 INR -0.84% Market Closed
Market Cap: 276.9B INR

Intrinsic Value

The intrinsic value of one GLAND stock under the Base Case scenario is 1 550.8 INR. Compared to the current market price of 1 680.6 INR, Gland Pharma Ltd is Overvalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLAND Intrinsic Value
1 550.8 INR
Overvaluation 8%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Gland Pharma Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about GLAND?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GLAND valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Gland Pharma Ltd.

Explain Valuation
Compare GLAND to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GLAND?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Gland Pharma Ltd

Current Assets 70.5B
Cash & Short-Term Investments 32B
Receivables 15.6B
Other Current Assets 22.8B
Non-Current Assets 47.5B
PP&E 42.2B
Intangibles 3.9B
Other Non-Current Assets 1.4B
Current Liabilities 17.1B
Accounts Payable 9.2B
Other Current Liabilities 7.8B
Non-Current Liabilities 5.3B
Long-Term Debt 1B
Other Non-Current Liabilities 4.3B
Efficiency

Free Cash Flow Analysis
Gland Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Gland Pharma Ltd

Revenue
58B INR
Cost of Revenue
-20.3B INR
Gross Profit
37.8B INR
Operating Expenses
-27.9B INR
Operating Income
9.9B INR
Other Expenses
-2B INR
Net Income
7.9B INR
Fundamental Scores

GLAND Profitability Score
Profitability Due Diligence

Gland Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROIC
Healthy Operating Margin
51/100
Profitability
Score

Gland Pharma Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

GLAND Solvency Score
Solvency Due Diligence

Gland Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Gland Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLAND Price Targets Summary
Gland Pharma Ltd

Wall Street analysts forecast GLAND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAND is 2 083 INR with a low forecast of 1 696.8 INR and a high forecast of 2 478 INR.

Lowest
Price Target
1 696.8 INR
1% Upside
Average
Price Target
2 083 INR
24% Upside
Highest
Price Target
2 478 INR
47% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLAND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GLAND stock?

The intrinsic value of one GLAND stock under the Base Case scenario is 1 550.8 INR.

Is GLAND stock undervalued or overvalued?

Compared to the current market price of 1 680.6 INR, Gland Pharma Ltd is Overvalued by 8%.

Back to Top